Long-Term Liabilities: The sum of all non-current liabilities.
Turnstone Biologics Corp. (TSBX) had Long-Term Liabilities of $0.37M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.81M |
|
-- |
|
-- |
|
$9.16M |
|
$-9.16M |
|
$-2.64M |
|
$-11.80M |
|
$-11.80M |
|
$-11.81M |
|
$-11.81M |
|
$-11.81M |
|
$-11.81M |
|
$-9.16M |
|
$-8.86M |
|
23.14M |
|
23.14M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$26.86M |
|
-- |
|
$0.76M |
|
$27.61M |
|
$7.26M |
|
-- |
|
|
Long-Term Liabilities |
$0.37M |
$7.63M |
|
$19.99M |
|
$19.99M |
|
$19.99M |
|
23.14M |
|
| Cash Flow Statement Financials | |
$-7.09M |
|
$0.01M |
|
-- |
|
$29.04M |
|
$21.96M |
|
$-7.08M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.07% |
|
-59.07% |
|
-42.76% |
|
-59.07% |
|
$0.86 |
|
$-0.31 |
|
$-0.31 |
|